PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16158213-1	2005	PURPOSE: The aim of this study was to develop quantitative structure-activity/pharmacokinetic relationships (QSAR/QSPKR) for a series of synthesized 1,4-dihydropyridines (DHPs) and pyridines as P-glycoprotein (P-gp) inhibitors.	Pyridines	160-169	ATP binding cassette subfamily B member 1	Homo sapiens	194-208	
16158213-1	2005	PURPOSE: The aim of this study was to develop quantitative structure-activity/pharmacokinetic relationships (QSAR/QSPKR) for a series of synthesized 1,4-dihydropyridines (DHPs) and pyridines as P-glycoprotein (P-gp) inhibitors.	Pyridines	160-169	ATP binding cassette subfamily B member 1	Homo sapiens	210-214	
16158213-10	2005	CONCLUSION: QSAR/QSPKR models were developed, and the QSAR models were capable of identifying synthesized 1,4-DHPs and pyridines with potent P-gp inhibition and reduced Ca2+ channel binding.	Pyridines	119-128	ATP binding cassette subfamily B member 1	Homo sapiens	141-145